
Zachary C. Tucker
Examiner (ID: 12965)
| Most Active Art Unit | 1624 |
| Art Unit(s) | 1624, 1623 |
| Total Applications | 603 |
| Issued Applications | 477 |
| Pending Applications | 25 |
| Abandoned Applications | 101 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 907771
[patent_doc_number] => 07332623
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-02-19
[patent_title] => 'Aryl-substituted acyclic enediyne compounds'
[patent_app_type] => utility
[patent_app_number] => 10/847667
[patent_app_country] => US
[patent_app_date] => 2004-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 15979
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/332/07332623.pdf
[firstpage_image] =>[orig_patent_app_number] => 10847667
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/847667 | Aryl-substituted acyclic enediyne compounds | May 17, 2004 | Issued |
Array
(
[id] => 7297526
[patent_doc_number] => 20040214846
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-28
[patent_title] => 'Compounds to treat Alzheimer\'s disease'
[patent_app_type] => new
[patent_app_number] => 10/847819
[patent_app_country] => US
[patent_app_date] => 2004-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40056
[patent_no_of_claims] => 141
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20040214846.pdf
[firstpage_image] =>[orig_patent_app_number] => 10847819
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/847819 | Compounds to treat Alzheimer's disease | May 17, 2004 | Issued |
Array
(
[id] => 523784
[patent_doc_number] => 07186832
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-03-06
[patent_title] => 'Use of 8-amino-aryl-substituted imidazopyrazines as kinase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/845586
[patent_app_country] => US
[patent_app_date] => 2004-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58610
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/186/07186832.pdf
[firstpage_image] =>[orig_patent_app_number] => 10845586
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/845586 | Use of 8-amino-aryl-substituted imidazopyrazines as kinase inhibitors | May 13, 2004 | Issued |
Array
(
[id] => 7083877
[patent_doc_number] => 20050049257
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-03
[patent_title] => 'Substituted aryl 1, 4-pyrazine derivatives'
[patent_app_type] => utility
[patent_app_number] => 10/844004
[patent_app_country] => US
[patent_app_date] => 2004-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 64125
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20050049257.pdf
[firstpage_image] =>[orig_patent_app_number] => 10844004
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/844004 | Substituted aryl 1, 4-pyrazine derivatives | May 11, 2004 | Issued |
Array
(
[id] => 7435638
[patent_doc_number] => 20040210059
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-21
[patent_title] => 'Production of mixed acid anhydride and amide compound'
[patent_app_type] => new
[patent_app_number] => 10/841644
[patent_app_country] => US
[patent_app_date] => 2004-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10973
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0210/20040210059.pdf
[firstpage_image] =>[orig_patent_app_number] => 10841644
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/841644 | Production of mixed acid anhydride and amide compound | May 9, 2004 | Issued |
Array
(
[id] => 448771
[patent_doc_number] => 07250418
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-07-31
[patent_title] => 'Compounds as CRF1 receptor antagonists'
[patent_app_type] => utility
[patent_app_number] => 10/840485
[patent_app_country] => US
[patent_app_date] => 2004-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18595
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/250/07250418.pdf
[firstpage_image] =>[orig_patent_app_number] => 10840485
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/840485 | Compounds as CRF1 receptor antagonists | May 5, 2004 | Issued |
Array
(
[id] => 7026815
[patent_doc_number] => 20050020601
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-27
[patent_title] => 'Novel pyrazinones as CRF1 receptor antagonists'
[patent_app_type] => utility
[patent_app_number] => 10/840484
[patent_app_country] => US
[patent_app_date] => 2004-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13749
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20050020601.pdf
[firstpage_image] =>[orig_patent_app_number] => 10840484
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/840484 | Novel pyrazinones as CRF1 receptor antagonists | May 5, 2004 | Abandoned |
Array
(
[id] => 609778
[patent_doc_number] => 07151178
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-12-19
[patent_title] => 'Method for the preparation of 5-methylpyrazine-2-carboxylic acid-4-oxide and its salts'
[patent_app_type] => utility
[patent_app_number] => 10/829886
[patent_app_country] => US
[patent_app_date] => 2004-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1872
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/151/07151178.pdf
[firstpage_image] =>[orig_patent_app_number] => 10829886
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/829886 | Method for the preparation of 5-methylpyrazine-2-carboxylic acid-4-oxide and its salts | Apr 21, 2004 | Issued |
Array
(
[id] => 630577
[patent_doc_number] => 07132538
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-11-07
[patent_title] => 'Isolation of high-purity triethylenediamine (TEDA) by distillation'
[patent_app_type] => utility
[patent_app_number] => 10/829176
[patent_app_country] => US
[patent_app_date] => 2004-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2351
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/132/07132538.pdf
[firstpage_image] =>[orig_patent_app_number] => 10829176
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/829176 | Isolation of high-purity triethylenediamine (TEDA) by distillation | Apr 21, 2004 | Issued |
Array
(
[id] => 460087
[patent_doc_number] => 07241766
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-07-10
[patent_title] => 'Methods of using phenolic guanidine sodium channel blockers'
[patent_app_type] => utility
[patent_app_number] => 10/828278
[patent_app_country] => US
[patent_app_date] => 2004-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16376
[patent_no_of_claims] => 80
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/241/07241766.pdf
[firstpage_image] =>[orig_patent_app_number] => 10828278
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/828278 | Methods of using phenolic guanidine sodium channel blockers | Apr 20, 2004 | Issued |
Array
(
[id] => 7190708
[patent_doc_number] => 20040204424
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-14
[patent_title] => 'Phenolic guanidine sodium channel blockers'
[patent_app_type] => new
[patent_app_number] => 10/828235
[patent_app_country] => US
[patent_app_date] => 2004-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16565
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20040204424.pdf
[firstpage_image] =>[orig_patent_app_number] => 10828235
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/828235 | Phenolic guanidine sodium channel blockers | Apr 20, 2004 | Issued |
Array
(
[id] => 516259
[patent_doc_number] => 07192960
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-03-20
[patent_title] => 'Sodium channel blockers'
[patent_app_type] => utility
[patent_app_number] => 10/828466
[patent_app_country] => US
[patent_app_date] => 2004-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 22640
[patent_no_of_claims] => 77
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/192/07192960.pdf
[firstpage_image] =>[orig_patent_app_number] => 10828466
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/828466 | Sodium channel blockers | Apr 20, 2004 | Issued |
Array
(
[id] => 516231
[patent_doc_number] => 07192958
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-03-20
[patent_title] => 'Sodium channel blockers'
[patent_app_type] => utility
[patent_app_number] => 10/828329
[patent_app_country] => US
[patent_app_date] => 2004-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16381
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/192/07192958.pdf
[firstpage_image] =>[orig_patent_app_number] => 10828329
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/828329 | Sodium channel blockers | Apr 20, 2004 | Issued |
Array
(
[id] => 7190718
[patent_doc_number] => 20040204425
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-14
[patent_title] => 'Sodium channel blockers'
[patent_app_type] => new
[patent_app_number] => 10/828352
[patent_app_country] => US
[patent_app_date] => 2004-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 22778
[patent_no_of_claims] => 79
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20040204425.pdf
[firstpage_image] =>[orig_patent_app_number] => 10828352
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/828352 | Sodium channel blockers | Apr 20, 2004 | Issued |
Array
(
[id] => 907366
[patent_doc_number] => 07332496
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-02-19
[patent_title] => 'Methods of using sodium channel blockers'
[patent_app_type] => utility
[patent_app_number] => 10/828479
[patent_app_country] => US
[patent_app_date] => 2004-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 22645
[patent_no_of_claims] => 118
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/332/07332496.pdf
[firstpage_image] =>[orig_patent_app_number] => 10828479
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/828479 | Methods of using sodium channel blockers | Apr 20, 2004 | Issued |
Array
(
[id] => 7466633
[patent_doc_number] => 20040198747
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-07
[patent_title] => 'Sodium channel blockers'
[patent_app_type] => new
[patent_app_number] => 10/828354
[patent_app_country] => US
[patent_app_date] => 2004-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16581
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0198/20040198747.pdf
[firstpage_image] =>[orig_patent_app_number] => 10828354
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/828354 | Sodium channel blockers | Apr 20, 2004 | Issued |
Array
(
[id] => 518920
[patent_doc_number] => 07189719
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-03-13
[patent_title] => 'Sodium channel blockers'
[patent_app_type] => utility
[patent_app_number] => 10/828171
[patent_app_country] => US
[patent_app_date] => 2004-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 22637
[patent_no_of_claims] => 77
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/189/07189719.pdf
[firstpage_image] =>[orig_patent_app_number] => 10828171
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/828171 | Sodium channel blockers | Apr 20, 2004 | Issued |
Array
(
[id] => 7466624
[patent_doc_number] => 20040198746
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-07
[patent_title] => 'Sodium channel blockers'
[patent_app_type] => new
[patent_app_number] => 10/828353
[patent_app_country] => US
[patent_app_date] => 2004-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16584
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0198/20040198746.pdf
[firstpage_image] =>[orig_patent_app_number] => 10828353
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/828353 | Sodium channel blockers | Apr 20, 2004 | Issued |
Array
(
[id] => 518971
[patent_doc_number] => 07189724
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-03-13
[patent_title] => 'Quinoxaline derivatives having antiviral activity'
[patent_app_type] => utility
[patent_app_number] => 10/826439
[patent_app_country] => US
[patent_app_date] => 2004-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7184
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/189/07189724.pdf
[firstpage_image] =>[orig_patent_app_number] => 10826439
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/826439 | Quinoxaline derivatives having antiviral activity | Apr 14, 2004 | Issued |
Array
(
[id] => 505502
[patent_doc_number] => 07202245
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-04-10
[patent_title] => 'Substituted 4-amino[1,2,4]triazolo[4,3-a] quinoxalines'
[patent_app_type] => utility
[patent_app_number] => 10/805885
[patent_app_country] => US
[patent_app_date] => 2004-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18876
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/202/07202245.pdf
[firstpage_image] =>[orig_patent_app_number] => 10805885
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/805885 | Substituted 4-amino[1,2,4]triazolo[4,3-a] quinoxalines | Mar 21, 2004 | Issued |